Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 19, Issue 2, 2011, Pages 99-105

  D'Souza, Jacob ^a   Clark, Jonathan ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

cutaneous squamous cell carcinoma; head and neck; high risk factors; lymph nodes; metastatic disease

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOSUPPRESSIVE AGENT;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; GENE AMPLIFICATION; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE METASTASIS; PAROTIDECTOMY; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA;

ALGORITHMS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; NECK DISSECTION; NEOPLASM METASTASIS; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; PAROTID GLAND; PAROTID NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79953884575     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e328343e811     Document Type: Review

References (53)

1. Staples M, Marks R, Giles G. Trends in the incidence of nonmelanocytic skin cancer treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer 1998; 78:144-148.
2. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998; 78:587-593. (Pubitemid 28507182)
3. Veness MJ, Porceddu S, Palme CE, et al. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 2007; 29:621-631. (Pubitemid 47168232)
4. Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008; 9:713-720.
5. Brewster DH, Bhatti LA, Inglis JH, et al. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003. Br J Dermatol 2007; 156:1295-1300.
6. Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer 2006; 106:1078-1083.
7. Clayman GL, Lee JJ, Holsinger FC, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005; 23:759-765. (Pubitemid 46237442)
8. Jambusaria-Pahlajani A, Miller CJ, Quon H, et al. Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg 2009; 35: 574-585.
9. Veness MJ. Defining patients with high-risk cutaneous squamous cell carcinoma. Aust J Derm 2006; 47:28-33.
10. Moore BA, Weber RS, Prieto V, et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 2005; 115:1561-1567. (Pubitemid 41330662)
11. O'Brien CJ. The parotid gland as a metastatic basin for cutaneous cancer. Arch Otolaryngol Head Neck Surg 2005; 131:551-555. (Pubitemid 41058040)
12. Lang PG Jr, Braun MA, Kwatra R. Aggressive squamous carcinomas of the scalp. Dermatol Surg 2006; 32:1163-1170. (Pubitemid 44370123)
13. Veness MJ, Quinn DI, Ong CS, et al. Aggressive cutaneous malignancy following cardiothoracic transplantation: an Australian experience. Cancer 1999; 185:1758-1764. (Pubitemid 29169677)
14. Martinez JC, Clark CO, Stasko T, et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients. Arch Dermatol 2003; 139:301-306. (Pubitemid 36330577)
15. Palme CE, O'Brien CJ, Veness MJ, et al. Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2003; 129:750-753. (Pubitemid 36858963)
16. Southwell KE, Chaplin JM, Eisenberg RL, et al. Effect of immunocompromise on metastatic squamous cell carcinoma in the parotid and neck. Head Neck 2006; 28:244-248. (Pubitemid 43269891)
17. Ch'ng S, Maitra A, Allison RS, et al. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma. J Surg Oncol 2008; 98:101-105.
18. Veness MJ, Palme CE, Smith M, et al. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope 2003; 113:1827-1833. (Pubitemid 37210989)
19. Khurana VG, Mentis DH, O'Brien CJ, et al. Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck. Am J Surg 1995; 170:446-450.
20. Forest VI, Clark JJ, Veness MJ, et al. N1S3: a revised staging system for head and neck squamous cell carcinoma with lymph node metastases. Cancer 2010; 116:1298-1304. This study proposes a new staging system according to the number and size of involved lymph nodes and incorporates parotid as one of the regional levels. The N1S3 system offers significant prognostic value.
21. O'Brien CJ, McNeil E, McMahon J, et al. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck 2001; 23:744-748. (Pubitemid 32754869)
22. Chu A, Osguthorpe JD. Nonmelanoma cutaneous malignancy with regional metastases. Otolaryngol Head Neck Surg 2003; 128:663-673. (Pubitemid 41123129)
23. Vauterin TJ, Veness MJ, Morgan GJ, et al. Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head Neck 2006; 28:785-791. (Pubitemid 44320530)
24. Kraus DH, Carew JF, Harrison LB. Regional lymph node metastases from cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1998; 124:582-587. (Pubitemid 28222350)
25. Netterville JL, Sinard RJ, Bryant GL, et al. Delayed regional metastases from midfacial squamous carcinomas. Head Neck 1998; 20:328-333. (Pubitemid 28183688)
26. Ebrahimi A, Moncrieff MD, Clark JR, et al. Predicting the pattern of regional metastases from cutaneous squamous cell carcinoma of the head and neck based on location of the primary. Head Neck 2010; 32:1288-1294. This study describes the patterns of nodal metastases based on the location of the index tumour and makes recommendations for a selective approach to the neck.
27. Del Charco JO, Mendenhall WM, Parsons JT, et al. Carcinoma of the skin metastatic to the parotid area lymph nodes. Head Neck 1998; 20:369-373. (Pubitemid 28288057)
28. Jol JA, van Velthuysen ML, Hilgers FJ, et al. Treatment results of regional metastases from cutaneous head and neck squamous cell carcinoma. Eur J Surg Oncol 2003; 29:81-86. (Pubitemid 36181783)
29. Weiss M, Harrison L, Isaacs R. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 1994; 120:699-702. (Pubitemid 24217580)
30. Wells K, Cruse C, Daniels S, et al. The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg 1994; 93:757-761. (Pubitemid 24083651)
31. Dona E, Veness MJ, Cakir B, et al. Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome. ANZ J Surg 2003; 73:692-696. (Pubitemid 37267115)
32. Cappiello J, Piazza C, Giudice M, et al. Shoulder disability after different selective neck dissections (levels II-IV versus levels II-V): a comparative study. Laryngoscope 2005; 115:259-263. (Pubitemid 40216699)
33. Corlette TH, Cole IE, Albsoul N, et al. Neck dissection of level IIb: is it really necessary? Laryngoscope 2005; 115:1624-1626.
34. Yoav PT. Problems in the current TNM staging of nonmelanoma skin cancer of the head and neck. Head Neck 2007; 29:525-527.
35. Veness MJ. Time to rethink TNM staging of cutaneous SCC. Lancet Oncol 2008; 9:702-703. (Pubitemid 352038311)
36. Palme CE, MacKay SG, Kaly I, et al. The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2007; 15:103-106. (Pubitemid 46594862)
37. O'Brien CJ, McNeil EB, McMahon JD, et al. Significance of clinical stage, extent of surgery, and pathological findings in metastatic cutaneous squamous cell carcinoma of the parotid gland. Head Neck 2002; 24:417-422. (Pubitemid 34506700)
38. American Joint Committee on Cancer. AJCC cancer staging handbook. 7th ed. New York: Springer; 2010.
39. Oddone N, Morgan GJ, Palme CE, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer 2009; 115:1883-1891. This study proposes a new staging system incorporating ITEM score to classify patients into three risk groups for assessment of treatment outcomes.
40. Veness MJ, Morgan GJ, Palme CE, et al. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope 2005; 115:870-875. (Pubitemid 40604696)
41. Postoperative concurrent chemo-radiotherapy versus postoperative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck (Post-Operative Skin Trial, POST study). Trans-Tasman Radiation Oncology Group, TROG; 5 January 2009.
42. Ch'ng S, Low I, Ng D, et al. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma. Hum Pathol 2008; 39:344-349.
43. Fogarty GB, Conus NM, Chu J, et al. Characterization of the expression and activation of the epidermal growth factor receptor in squamous cell carcinoma of the skin. Br J Dermatol 2007; 156:92-98. (Pubitemid 44924151)
44. Gold KA, Lee HY, Kim ES. Targeted therapies in squamous cell carcinoma of the head and neck. Cancer 2009; 115:922-935.
45. Temam S, Kawaguchi H, El-Naggar AK, et al. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. J Clin Oncol 2007; 25:2164-2170. (Pubitemid 46954638)
46. Kivisaari AK, Kallajoki M, Ala-aho R, et al. Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma. Br J Dermatol 2010; 163:726-735.
47. Alex J. The application of sentinel node radiolocalization to solid tumors of the head and neck: a 10-year experience. Laryngoscope 2004; 114:2-19. (Pubitemid 38141060)
48. Ross AS, Schmults CD. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg 2006; 32:1309-1321. (Pubitemid 44691132)
49. Renzi C, Caggiati A, Mannooranparampil TJ, et al. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature. Eur J Surg Oncol 2007; 33:364-369. (Pubitemid 46488665)
50. Weisberg N, Bertagnolli M, Becker D. Combined sentinel lymphadenectomy and mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2000; 43:483-488. (Pubitemid 30666740)
51. Reschly MJ, Messina JL, Zaulyanov LL, et al. Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2003; 29:135-140. (Pubitemid 36188419)
52. Wagner JD, Evdokimow DZ, Weisberger E. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol 2004; 140:75-79. (Pubitemid 38090273)
53. Civantos F Jr, Zitsch R, Bared A, Amin A. Sentinel node biopsy for squamous cell carcinoma of the head and neck. J Surg Oncol 2008; 97:683-690. (Pubitemid 351825748)